Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 2/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 6/20 | 0.38 |
| ▸ | MMP13 | P45452 | 6/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27367224 | 0.82 | AKR1C3 (0.45) | AKR1C3AKR1C2ALDH1A1SMN1; SMN2AOC3 | |
| SCHEMBL27367231 | 0.78 | MMP2 (0.43) | MMP2MMP13ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL29700742 | 0.64 | AOC3 (0.59) | AOC3 | |
| SCHEMBL22076569 | 0.64 | CYP2D6 (0.55) | AOC3 | |
| SCHEMBL23536576 | 0.63 | ALDH1A1 (0.52) | ALDH1A1OPRM1OPRD1LMNAHTT | |
| SCHEMBL29964126 | 0.63 | NPC1 (0.61) | ALDH1A1LMNAHTTSMN1; SMN2 | |
| SCHEMBL29212110 | 0.63 | NPC1 (0.61) | ALDH1A1LMNAHTTSMN1; SMN2 | |
| SCHEMBL27367160 | 0.63 | CYP2C9 (0.52) | ALDH1A1SMN1; SMN2GAA | |
| SCHEMBL12600119 | 0.63 | CYP2D6 (0.39) | AKR1C3AKR1C2ALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL27367215 | 0.61 | AOC3 (0.36) | AKR1C3AKR1C2LMNAAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024049929-A2 | PANNEXIN-1 MODULATORS AND METHODS OF TREATING DISORDERS IN WHICH PANNEXIN-1 IS IMPLICATED | PANNEX THERAPEUTICS INC. (US) | 2024-03-07 | — | — | WO | disclosed |